白云山(600332.SH)：分公司获得药品补充申请批件

Core Viewpoint - The company, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, has received approval from the National Medical Products Administration for a supplemental application regarding the drug Cefuroxime Sodium for injection, which is a second-generation cephalosporin antibiotic with broad-spectrum efficacy against both Gram-negative and Gram-positive bacteria [1] Group 1 - The approved drug, Cefuroxime Sodium, is clinically used for treating respiratory infections, urinary tract infections, and surgical infections [1] - Cefuroxime Sodium is noted for its low renal toxicity and stability against β-lactamase, making it advantageous in clinical applications [1]